Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation
Gianluigi Bisleri(St. Michael's Hospital), Andrew C.T. Ha(University Health Network), Syed M. Ali Hassan(University of Toronto), Atul Verma(McGill University Health Centre), Bobby Yanagawa(St. Michael's Hospital), Arjun Pandey(University of Ottawa), Mario Gaudino(Cornell University), Subodh Verma(St. Michael's Hospital), Andrea M. Russo(Cooper Medical School of Rowan University), Masud H. Khandaker(William Osler Health System), Deepak L. Bhatt(Mount Sinai Hospital)
Cited by 15
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k